Natural gas futures fall for 10th straight session, but strategist predicts rebound if trade tensions ease. Strong demand and low inventory support. read more
Edwards Lifesciences raised 2025 revenue forecast after Q1 results beat EPS estimates and TMTT sales jumped 58% amid strong global demand. Latest Ratings for EW Date Firm Action From To Feb 2022 UBS Upgrades Neutral Buy Jan 2022 Morgan Stanley Maintains Overweight Jan 2022 Raymond James Maintains Outperform View More Analyst Ratings for EW View…
Cryptocurrency markets are showing muted price action on Thursday. read more
Coinbase Global, Inc. (NASDAQ:COIN) shares are trading higher on Thursday. read more
Emerging markets thrive despite tariff chaos, best positioned to weather volatility: India, UAE, LatAm, and Australia stand out. Defensive sectors and gold are also key for a tariff-resistant portfolio. read more
IBM shares tank despite upbeat Q1 earnings. Analysts maintain Buy rating and $270 price target. Stock decline appears overdone. Latest Ratings for IBM Date Firm Action From To Jan 2022 BMO Capital Maintains Market Perform Jan 2022 UBS Downgrades Neutral Sell Jan 2022 Goldman Sachs Initiates Coverage On Neutral View More Analyst Ratings for IBM…
Keurig Dr Pepper beats Q1 estimates and reaffirms FY25 outlook, as strong beverage growth offsets coffee sales decline. read more
Bitcoin (CRYPTO: BTC) has briefly reclaimed the Short-Term Holder (STH) Cost Basis of $92,900, a key on-chain level that historically separates bullish and bearish market regimes, according to a Glassnode report on Thursday. read more